Guardant Health
GH
#1121
Rank
NZ$37.66 B
Marketcap
NZ$278.41
Share price
-0.17%
Change (1 day)
61.19%
Change (1 year)
Guardant Health is an American company developing blood tests for early detection in high-risk populations and recurrence monitoring in cancer survivors.

Annual Reports

Thumbnail Guardant Health
 Annual Report 2022

Annual Report 2022

Language: English

View Annual Report